Back

The role of exhaled breath acetone and BNP in predicting outcomes in advanced heart failure

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers and prognosis in acute heart failure Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Daniella Motta Da Costa Dan

Rede Meridional Hospital, Vitoria (Brazil)

7 More presentations in this session

Presentation thumbnail
Association between high serum uric acid and poor outcomes in patients with acute heart failure.
Doctor F. Qorina (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic performance of insulin-like growth factor-binding protein 7 in patients with acute dyspnea in the emergency department
Ms C. Popescu (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study
Ms E. Ghanbari (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Admission natriuresis as a predictor of outcomes in acute decompensated heart failure
Mr J. Iroulart (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without interleukin-1 blockade by anakinra
Doctor A. Abbate (Charlottesville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers and prognosis in acute heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Risk stratification for heart transplant listing or death in patients with heart failure profile C - a classification and regression tree CART analysis
thumbnail
Congress Presentation
Exhaled breath acetone as a biomarker of disease severity and exercise intolerance in heart failure
thumbnail
Congress Presentation
Non-invasive bioimpedance analysis predicts NT-proBNP changes during hospitalization in a cohort of acutely decompensated heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources